Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

During the Trading Day
3.44 +0.05 / +1.47%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
3.44 +0.0007 / +0.02%
Volume: 3.6K
Health Technology
Pharmaceuticals: Other

Company Description

Corcept Therapeutics, Inc. is engaged in the development of drugs for the treatment of severe psychiatric, neurological and metabolic disorders in the United States. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. The company's products include korlym, cushing's syndrome, CORT 108297 and weight gain mitigation. Corcept Therapeutics was founded by David B. Singer and Joseph K. Belanoff On May 13, 1998 by and is headquartered in Menlo Park, CA.

Contact Information

Corcept Therapeutics, Inc.
149 Commonwealth Drive
Menlo Park California 94025
P:(650) 327-3270
Investor Relations:
(650) 688-8783



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Joseph K. BelanoffPresident, Chief Executive Officer, Director & MD
Gary Charles RobbSecretary, Chief Financial & Accounting Officer
Hazel HuntVice President-Research
Thaddeus S. BlockVice President-Clinical Development
Robert S. FishmanChief Medical Officer